Article · 2018
Editor
Gregory Lee
Professor, University of British Columbia, Canada
About
As published by the journal they serve.
Upon completion of his Ph D degree in Biophysical Chemistry at California Institute of Technology in 1972, he joined UCSD as a NIH Postdoctoral Fellow to carry out pioneer work on general ligand affinity chromatography. In 1976, he studied enzymology and biochemical genetic at the National Institute of Health and in 1981, he was appointed as a faculty member and director of the Andrology Laboratory at the University of British Columbia. During the last two decades, he has created numerous monoclonal antibodies for diagnostic and therapeutic applications in human health care, including RP215 and GHR106 for potential use as anti-cancer drugs.
Research interests
Journals they serve
The seats these journals name them in.
- Biochemistry & Physiology: Open AccessEditor
- Cervical Cancer: Open AccessEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2018
Cancerous immunoglobulins and potential clinical applications
Article · 2018
Anti-GnRH receptor monoclonal antibodies are long acting biosimilar GnRH antagonists
Article · 2015
Anti-GNRH receptor monoclonal antibodies as bioequivalent analogs of GNRH
Article · 2015
First-in-class GnRH analog for cancer therapy
Article · 2013
Carbohydrate-associated epitope-based anti-cancer drugs and vaccines
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
